Pharvaris is a clinical-stage company focused on bringing oral bradykinin-B2-receptor antagonists to patients.
There are
51 – 200
employees in the company
Below 1M
Company annual revenue
Offices
Pharvaris was founded in October 2015 by executives with a breadth of expertise across pharmaceutical development and rare disorders, including HAE.
The company is internationally based and growing quickly.